Table 2.

Characteristics of the patients upon inclusion in the study

Case	SOFA score	Antibiotics	Vasoactive drugs	CRRT	Procalcitonin, ng/mL	Temperature, °C	Leukocytes,/mm3	Final diagnosis
1	11	Yes	Yes	No	96.46	39.0	9,800	Systemic infectiona
3	14	Yes	Yes	No	40.9	37.0	1,100	Systemic infectionb
4	12	Yes	No	No	1.28	36.4	7,600	VAP
5	16	Yes	No	No	18.62	40.0	0	Enteritis + VAP
6	12	Yes	Yes	Yes	15.0	38.6	21,200	VAP + infected pancreatitis
7	13	Yes	Yes	No	3,054	38.8	11,700	Nosocomial pneumonia
8	16	Yes	Yes	No	3.5	39.0	2,900	VAP
9	14	Yes	Yes	No	10.38	28.0	20,400	HAP
10	15	Yes	Yes	Yes	50.0	38.0	11,600	VAP + infected pancreatitis
11	9	Yes	Yes	No	4.53	37.8	14,100	VAP
12	11	Yes	No	Yes	13.0	38.2	7,600	Infected pancreatitis
13	11	Yes	No	No	0.833	38.0	12,700	SBP
14	11	Yes	Yes	No	68.65	40.0	13,200	Enteritis
15	21	Yes	Yes	No	19.3	37.6	12,400	SBP
16	16	Yes	Yes	No	7.9	39.3	200	Enteritis
17	6	Yes	No	No	0.784	36.0	6,600	Systemic infectionc
18	7	Yes	No	No	0.49	38.8	11,900	HAP
19	16	Yes	Yes	No	0.90	37.0	6,100	HAP
20	12	Yes	Yes	Yes	10.74	38.8	23,200	VAP
21	12	Yes	No	No	2.41	38.7	3,100	VAP
22	14	Yes	Yes	No	4.44	38.0	16,300	VAP + SBP

Patient 2 was removed from the analyses because of our inability to aspirate peritoneal fluid. 'Systemic infection' indicates that the same infection affected both the abdomen and lungs: ^aseptic thrombophlebitis of the portal vein by Salmonella tiphy with hematogenous pneumonia; ^bcitomegaloviruses colitis and pneumonia; ^csystemic infection (lung + abdominal) by Aspergillus fumigates. CRRT, continuous renal replacement therapy; HAP, hospital-acquired pneumonia; SBP, spontaneous bacterial peritonitis; SOFA, Sepsis-related Organ Failure Assessment; VAP, ventilator-associated pneumonia.